Pancreatic Cancer Research

ResearcherTianjin Medical University Cancer Institute and HospitalActive in the last 2 years

Li Ren

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0003-6139-0647; OpenAlex author ID A5100640478. Sources: OpenAlex.

Their work

Papers
5 (first author 0, last author 4)
Trials
0
Grants
0
Labs led
1
Collaborators
11
Papers, trials and grants by year

2020: 2 papers · 2021: 1 paper · 2022: 1 paper · 2023: none · 2024: 1 paper

Papers 5

  1. Solute carrier family 16 member 1 as a potential prognostic factor for pancreatic ductal adenocarcinoma and its influence on tumor immunity. Last author DOI 10.21037/jgo-24-147↗
  2. Clinical Analysis of Bloodstream Infection of Escherichia coli in Patients with Pancreatic Cancer from 2011 to 2019. Co-author DOI 10.1155/2022/1338188↗
  3. Serum Exosomal EphA2 is a Prognostic Biomarker in Patients with Pancreatic Cancer. Last author DOI 10.2147/cmar.s304719↗
  4. Serum Exo-EphA2 as a Potential Diagnostic Biomarker for Pancreatic Cancer. Last author DOI 10.1097/mpa.0000000000001660↗
  5. EphA2‑enriched exosomes promote cell migration and are a potential diagnostic serum marker in pancreatic cancer. Last author DOI 10.3892/mmr.2020.11384↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Qian Wei · 2 shared papers, 2020–2021 · strength 0.33
  2. Lijuan Wei · 2 shared papers, 2020 · strength 0.28
  3. Abhinav V. Reddy · 1 shared paper, 2024 · strength 0.20
  4. Meng Wang · 1 shared paper, 2024 · strength 0.20
  5. Shinichi Ikuta · 1 shared paper, 2024 · strength 0.20
  6. Alice Talbot · 1 shared paper, 2024 · strength 0.20
  7. Wenna Jiang · 1 shared paper, 2024 · strength 0.20
  8. Yueguo Li · 1 shared paper, 2022 · strength 0.16
  9. Changsen Bai · 1 shared paper, 2022 · strength 0.16
  10. Li Ding · 1 shared paper, 2022 · strength 0.16
  11. Qian Wei · 1 shared paper, 2020 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.